GlassScriptPhysician profile
Jamie Briddell
NPI 1659981728
$778.98
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $388 · 2022: $391.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $198.68 | 2021-2022 | |
| Novo Nordisk INC | $121.31 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $119.04 | 2021-2022 | |
| Abbvie INC. | $110.52 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $71.50 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $37.95 | 2021 | |
| Abbott Laboratories | $26.82 | 2021-2022 | |
| Tandem Diabetes Care, INC. | $24.36 | 2022 | |
| Corcept Therapeutics | $22.18 | 2021 | |
| Mannkind Corporation | $18.52 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $15.34 | 2021 | |
| Zealand Pharma US, INC. | $12.76 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jamie Briddell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.